Product |
CAS?? |
Molecular formula |
More |
5-(4-Methylphenyl)isoxazole-4-carboxylic acid |
887408-19-7 |
C11H9NO3 |
More |
2-(4-Methoxybenzyloxy)-3-bromo-4-methylpyridine |
1003312-15-9 |
C14H14BrNO2 |
More |
6-(2-(4-Methoxybenzyloxy)-4-methylpyridin-3-yl)quinazolin-2-amine |
1003312-16-0 |
C22H20N4O2 |
More |
2-(7-Methoxyquinolin-4-yloxy)acetic acid |
1002308-53-3 |
C12H11NO4 |
More |
(6-(3-Methylisothiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)meth |
1002308-65-7 |
C10H10N6S |
More |
4-Methyl-n-(1-methyl-1h-pyrazol-5-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dio |
1011460-39-1 |
C18H24BN3O3 |
More |
Methyl 3-iodo-1-tosyl-1h-indole-5-carboxylate |
1027787-65-0 |
C17H14INO4S |
More |
2-(4-Methyl-1h-imidazol-1-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborola |
1416252-92-0 |
C15H20BN3O2 |
More |
2-(4-Methyl-1-piperidinyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2 |
1402174-17-7 |
C16H26BN3O2 |
More |
2-(2-Methyl-1-piperidinyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2 |
1401350-33-1 |
C16H26BN3O2 |
More |
Methyl 2-chloro-4-cyclopropylpyrimidine-5-carboxylate |
1401350-08-0 |
C9H9ClN2O2 |
More |
5-[5-(Methylthio)-1,3,4-thiadiazol-2-yl]-1h-indole |
1401348-60-4 |
C11H9N3S2 |
More |
5-[3-[6-(4-Morpholinyl)-2-pyridinyl]-1h-indol-5-yl]-2-thiazolamine |
1401347-36-1 |
C20H19N5OS |
More |
5-[3-(6-Methoxy-2-pyrazinyl)-1h-indol-5-yl]-1,3,4-thiadiazol-2-amine |
1401347-35-0 |
C15H12N6OS |
More |
5-[3-[2-(2-Methyl-1-piperidinyl)-4-thiazolyl]-1h-indol-5-yl]-1,3,4-thi |
1401347-08-7 |
C19H20N6S2 |
More |
5-[3-[2-(4-Morpholinyl)-4-pyrimidinyl]-1h-indol-5-yl]-1,3,4-thiadiazol |
1401346-58-4 |
C18H17N7OS |
More |
5-[3-[1-[2-(4-Morpholinyl)ethyl]-1h-pyrazol-4-yl]-1h-indol-5-yl]-1,3,4 |
1401346-08-4 |
C19H21N7O2 |
More |
5-[3-[1-(2-Methylpropyl)-1h-pyrazol-4-yl]-1h-indol-5-yl]-1,3,4-oxadiaz |
1401346-07-3 |
C17H18N6O |
More |
5-[3-[6-(4-Methyl-1-piperazinyl)-2-pyridinyl]-1h-indol-5-yl]-1,3,4-oxa |
1401346-02-8 |
C20H21N7O |
More |
5-[3-[6-(4-Morpholinyl)-2-pyridinyl]-1h-indol-5-yl]-1,3,4-thiadiazol-2 |
1401345-36-5 |
C19H17N5O2S |
More |